ScoreWhy is Akoya Biosciences, Inc. ?
1
Flat results in Mar 25
- ROCE(HY) Lowest at -354.27%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.49%
- NET SALES(Q) Lowest at USD 16.64
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -37.38%, its profits have risen by 25.2%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -37.38% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Akoya Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Akoya Biosciences, Inc.
-37.38%
-0.49
85.42%
S&P 500
11.09%
0.85
20.38%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.29%
EBIT Growth (5y)
6.68%
EBIT to Interest (avg)
-9.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-8.86
Sales to Capital Employed (avg)
0.81
Tax Ratio
0.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
37.09%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-9.82
EV to EBIT
-2.94
EV to EBITDA
-3.70
EV to Capital Employed
2.38
EV to Sales
1.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-80.86%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -30.49 MM
NET PROFIT(HY)
Higher at USD -23.72 MM
RAW MATERIAL COST(Y)
Fallen by -8.46% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -953.97 %
-9What is not working for the Company
ROCE(HY)
Lowest at -354.27%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.49%
NET SALES(Q)
Lowest at USD 16.64 MM
Here's what is working for Akoya Biosciences, Inc.
Operating Cash Flow
Highest at USD -30.49 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -23.72 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at -953.97 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -8.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Akoya Biosciences, Inc.
Inventory Turnover Ratio
Lowest at 1.49% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
Lowest at USD 16.64 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
